IP Library Granted Patent US 11,850,242
Granted Patent B2
US 11,850,242 · App. 17/660,479 · Granted Dec 26, 2023

Methods and compositions for improving sleep

Inventor: Jose Bernardo (Oxnard, CA)
A61K31/4415A61K9/006A61K31/015A61K31/198A61K31/4045A61K47/10A61K47/26A61K47/38A61K47/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,850,242
App. No.
17/660,479
Granted
Dec 26, 2023
Kind
B2
Abstract

Compositions suitable for oral use (e.g., oral thin film) containing various excipients and a combination of melatonin, caryophyllene, GABA, L-theanine, and vitamin B 6 . Methods of using the composition, e.g., in the treatment of a sleeping disorder, as well as methods of manufacturing the composition are also included.

Claims (12)

1. An oral thin film having a mass of about 110-130 mg, the thin film comprising:

(i) 1.5±0.5 mg N-acetyl-5-methoxy tryptamine (melatonin),

(ii) 15±5 mg (−)-β-caryophyllene (caryophyllene),

(iii) 7.5±3 mg 4-aminobutanoic acid (GABA),

(iv) 12±6 mg L-γ-glutamylethylamide (L-theanine),

(v) 3±2 mg pyridoxine (vitamin B6),

(vi) 29±15 mg in the aggregate of at least one of binder, thickening agent, and gelling agent,

(vii) 10±4 mg plasticizer,

(viii) 2±1 mg lipid,

(ix) 8±5 mg flavoring agent, and

(x) 8±5 mg sweetener.

2. The oral thin film of claim 1 , having the following dimensions: 44±4 mm×22±2 mm×0.12±0.01 mm.

Assignments (6)
LIEN Recorded Jan 28, 2025
From: CURE PHARMACEUTICAL, INC.
To: CUREX PHARMACEUTICAL MEXICO S.A.P.I. DE C.V.
Reel/Frame 070027/0201 →
CHANGE OF NAME Recorded Jul 17, 2023
From: TF TECH VENTURES, INC.
To: CURE PHARMACEUTICAL, INC.
Reel/Frame 064286/0450 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME WHICH SHOULD READ TF TECH VENTURES, INC. AND NOT TF TECH VENTURES PREVIOUSLY RECORDED AT REEL: 060598 FRAME: 0016. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 12, 2023
From: CURE PHARMACEUTICAL CORPORATION
To: TF TECH VENTURES, INC.
Reel/Frame 064256/0361 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2022
From: CURE PHARMACEUTICAL CORPORATION
To: TF TECH VENTURES
Reel/Frame 060598/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2022
From: CURE PHARMACEUTICAL HOLDING CORP.
To: CURE PHARMACEUTICAL CORPORATION
Reel/Frame 060516/0576 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2022
From: BERNARDO, JOSE
To: CURE PHARMACEUTICAL HOLDING CORP.
Reel/Frame 060012/0971 →
Continuity (2)
Continuation 16432443 · Jun 5, 2019
Related Publication 20220257579A1 · Aug 18, 2022